New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease
News published by Insmed Incorporated concerning ARIKAYCE® (amikacin liposome inhalation suspension), administered with Lamira®, an optimized eFlow® Technology nebulizer.